Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival

Huifang Tang1, Gongda Xue2

  • 1Department of Pharmacology, Zhejiang University, School of Basic Medical Sciences, Hangzhou, 310058, China. tanghuifang@zju.edu.cn.

Insights

Targeted cancer therapies face drug resistance due to pro-survival signaling crosstalk. Interfering with this network may overcome acquired resistance, improving treatment efficacy.

Area of Science:

  • Cellular signaling pathways
  • Cancer biology
  • Drug resistance mechanisms

Background:

  • Cell proliferation and survival are tightly regulated by signaling pathways crucial for development.
  • Key pathways like PI3K/Akt, Ras/MAPK, and JAK/STAT promote cell growth, differentiation, and survival.
  • Acquired drug resistance is a major hurdle in clinical cancer therapy.

Purpose of the Study:

  • To investigate the role of intrinsic pro-survival signaling crosstalk in acquired resistance to targeted cancer therapies.
  • To explore potential therapeutic strategies to overcome drug resistance by targeting signaling networks.

Main Methods:

  • Analysis of key signaling pathways (PI3K/Akt, Ras/MAPK, JAK/STAT) involved in cell survival.
  • Investigating the functional interactions and crosstalk between these signaling axes.
  • Evaluating the impact of interfering with signaling crosstalk on drug resistance in preclinical models (implied).

Main Results:

  • Identified intrinsic pro-survival signaling crosstalk as a driving force in acquired resistance.
  • Demonstrated the critical role of pathways like PI3K/Akt, Ras/MAPK, and JAK/STAT in maintaining cell survival.
  • Highlighted the potential of targeting this crosstalk to overcome resistance.

Conclusions:

  • Signaling pathway crosstalk is fundamental to overcoming drug resistance in cancer therapy.
  • Interfering with cross-reacting networks offers a promising strategy to enhance the effectiveness of targeted therapies.
  • Further research into these networks could lead to novel therapeutic approaches for resistant cancers.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
12.2K